Propavan

Propavan is owned by CNX Therapeutics, headquartered in the United Kingdom. No. The ultimate owner of Propavan, CNX Therapeutics, is headquartered in the United Kingdom, not in the United States.

CNX Therapeutics is a specialty pharmaceutical company focused on the acquisition and commercialization of critical medicines, particularly in the fields of CNS and hospital care.